![Seong-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Jin Kim
Chief Executive Officer at
MEDPACTO, INC.
Net worth: 6 M $ as of 2026-06-29
Profile
Seong-Jin Kim is the founder of MedPacto, Inc. (2013) as Chief Executive Officer, Director & CTO.
Dr. Kim is the founder of Celloram, Inc. (2018) as Director.
Dr. Kim is currently the Head-Cancer Institute at CHA University.
Formerly, Dr. Kim served as Independent Director, Head-Research & Development at THERAGEN ETEX Co., Ltd. Education includes a doctorate from the University of Tsukuba.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MEDPACTO, INC. 6.36% | 2025-03-14 | 2,181,216 ( 6.36% ) | 4 M $ | 2026-06-29 |
| 2025-03-14 | 1,059,025 ( 2.85% ) | 1 M $ | 2026-06-29 |
Seong-Jin Kim active positions
| Companies | Position | Start |
|---|---|---|
| MEDPACTO, INC. | Chief Executive Officer | 2013-06-18 |
CHA University
 CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-06-30 |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Founder | 2017-12-31 |
Former positions of Seong-Jin Kim
| Companies | Position | End |
|---|---|---|
| THERAGEN ETEX CO.,LTD. | Chief Tech/Sci/R&D Officer | - |
Training of Seong-Jin Kim
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
3
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Tsukuba
 University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
THERAGEN ETEX Co., Ltd.
 THERAGEN ETEX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
CHA University
CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPacto, Inc.
 MedPacto, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops anti-cancer drugs | Health Technology |
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Health Technology |
- Stock Market
- Insiders
- Seong-Jin Kim
